Structure and properties of pharmacologically active polymers
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Although the concept of using pharmacologically active macromolecular compounds as drugs is still regarded with much skepticism for both theoretical and practical reasons, interest in this field has grown in recent years because of the opportunity to take advantage of the specific properties of polymeric materials. For low molecular weight drugs, changes in structure often lead to a loss of specific activity. On the other hand, the properties of macromolecular drugs depend on the structure of the polymer used and this can be varied over a wide range by the incorporation of comonomer units, by the application of polymer‐analogous reactions, or by related structural changes. A new model is presented for pharmacologically active polymers which incorporates the possibility for continuous variation in (a) solubility and toxicity, (b) fixation and removal of active material, and (c) body distribution. Using the new model as a guide, examples of the synthesis and study of the biological activity of various macromolecular drugs are presented in order to emphasize the importance of this cooperative effort between polymer research and therapeutic problems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The drug-polymer conjugates were introduced in the early work by Helmut Ringsdorf in 1970s to improve drug solubility, toxicity, and body biodistribution, which was followed by extensive studies on the development of drug-polymer conjugates [143, 144].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [144]
Citations
Cites
de Duve, C., & Wattiaux, R. (1966) · Annual Review of Physiology · doi:10.1146/annurev.ph.28.030166.002251 · Cited by 3,033
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Chang, T. M. S. (1964) · Science · doi:10.1126/science.146.3643.524 · Cited by 1,011
Lysosomes in Biology and Pathology
Lagunoff, D. (1974) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1974.03230160059035 · Cited by 887
AN EXAMINATION OF THE CYTOTOXIC EFFECTS OF SILICA ON MACROPHAGES
Allison, A. C., Harington, J. S., & Birbeck, M. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.124.2.141 · Cited by 871
FACTOR-VIII COMPLEX AND ENDOTHELIAL DAMAGE
Boneu, B., Abbal, M., Plante, J., & Bierme, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92650-1 · Cited by 716
de Duve, C. (2008) · Novartis Foundation Symposia · doi:10.1002/9780470715314.ch1 · Cited by 473
DRUG-CARRIER POTENTIAL OF LIPOSOMES IN CANCER CHEMOTHERAPY
Gregoriadis, G., Swain, C. P., Wills, E. J., & Tavill, A. S. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90682-5 · Cited by 401
Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization
Kopeček, J., & Baẑilová, H. (1973) · European Polymer Journal · doi:10.1016/0014-3057(73)90063-3 · Cited by 300
Ryser, H. J.-P. (1968) · Science · doi:10.1126/science.159.3813.390 · Cited by 288
Research works printed but not linked: 20
- Lee H., 1971, Handbook for Surgery and Artificial Organs
- Kabaiwanow W., 1972, Plaste Kaut., 19, 886
- Wessel W., 1971, Arzeim. Forsch., 21, 1468
- Ryser H. J. P., 1970, Proc. Fourth Int. Cong. Pharm., 3, 96
- 1965, Silikose Forsch., 6, 213
- Ferruti P., 1966, Med. Lav., 57, 481
- V.Hofmann dissertation University of Mainz 1975.
- Burger A., 1970, Medicinal Chemistry, 1185
- Donaruma L. G., 1974, Prog. Polym. Sci., 4, 18
- G.Franzmann dissertation University of Mainz 1975.
- H.Morawetzet al. in press.
- Ringsdorf H., 1967, Strahlentherapie, 132, 627
- Busch H., 1961, Cancer Res., 21, 271
- H.Ritter dissertation University of Mainz 1975.
- M.Przybylski dissertation University of Mainz 1975.
- Jacob S. W., 1971, Dimethylsulfoxide
- V.Hofmann H.Ringsdorf andG.Muacevic Makromol. Chem. in press.
- Jacques P. J., 1966, Rev. Quest. Sci., 27, 99
- Jacques P. J., 1969, Lysosomes in Biology and Pathology, 395
- Szekerke M., 1972, Neoplasma, 19, 211
Cited by
Items 401–500 of 1,000
Inoue, K., Kumazawa, E., Kuga, H., Susaki, H., Masubuchi, N., & Kajimura, T. (2004) · Advances in experimental medicine and biology · doi:10.1007/0-306-47932-x_9 · Cited by 35
Nanomedicine in cancer stem cell therapy: from fringe to forefront
Tabassum, N., Verma, V., Kumar, M., Kumar, S. K. A., & Singh, B. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2928-5 · Cited by 34
“…NPs of various sizes and properties such as liposomes (Gregoriadis et al. 1971), DNA–drug complexes (Cornu et al. 1974), polymer–drug conjugates (Ringsdorf 1975), antibody– drug conjugates (Hurwitz et al. 1975), polymer nanocapsules (Couvreur et al. 1977), polymer–protein conjugates (Davis…”
BackgroundWang, L., Tian, B., Zhang, J., Li, K., Liang, Y., Sun, Y., Ding, Y., & Han, J. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.02.002 · Cited by 34
New derivatives of polyglutamic acid as drug carrier systems
Hoste, K., Schacht, E. H., & Seymour, L. W. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00142-x · Cited by 34
Synthesis of Tailor-Made Soluble Polymeric Drug Carriers
Kopec̆ek, J. (1984) · Springer eBooks · doi:10.1007/978-1-4613-2745-5_4 · Cited by 37
Hoffman, A. S. (1992) · Artificial Organs · doi:10.1111/j.1525-1594.1992.tb00266.x · Cited by 40
Water‐Soluble Metallocene‐Containing Polymers
Alkan, A., & Wurm, F. R. (2016) · Macromolecular Rapid Communications · doi:10.1002/marc.201600205 · Cited by 35
Figueroa, S. M., Fleischmann, D., Beck, S., Tauber, P., Witzgall, R., Schweda, F., & Göpferich, A. M. (2020) · Advanced Science · doi:10.1002/advs.201903204 · Cited by 33
Vinyl Polymer-based technologies towards the efficient delivery of chemotherapeutic drugs
Pereira, P., Serra, A. C., & Coelho, J. F. J. (2021) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2021.101432 · Cited by 34
Synthesis, characterization, in vitro and in vivo evaluation of PEGylated oridonin conjugates
Shen, J., Zhang, D., Zhao, Z., Jia, L., Zheng, D., Liu, G., Hao, L., Zhang, Q., Tian, X., Li, C., et al. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.08.014 · Cited by 35
Abdellaoui, K., Boustta, M., Vert, M., Morjani, H., & Manfait, M. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)00069-9 · Cited by 33
Williams, C. C., Thang, S. H., Hantke, T., Vogel, U., Seeberger, P. H., Tsanaktsidis, J., & Lepenies, B. (2011) · ChemMedChem · doi:10.1002/cmdc.201100456 · Cited by 32
Preparation of Well-Defined Ibuprofen Prodrug Micelles by RAFT Polymerization
Hasegawa, U., van der Vlies, A. J., Wandrey, C., & Hubbell, J. A. (2013) · Biomacromolecules · doi:10.1021/bm4009149 · Cited by 32
Development of functional polyplex micelles for systemic gene therapy
Osada, K. (2014) · Polymer Journal · doi:10.1038/pj.2014.49 · Cited by 32
Huang, T., AlSalem, H. S., Binkadem, M. S., Al‐Goul, S. T., El-kott, A. F., Alsayegh, A. A., Majdou, G. J., Batiha, G. E., & Karmakar, B. (2022) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2022.101505 · Cited by 33
“Nanoparticles have good potential for preventing the diagnosis and treatment of cancer [9–13].”
Cytotoxicity of ferrocenyl-ethynyl phosphine metal complexes of gold and platinum.
Fourie, E., Erasmus, E., Swarts, J. C., Jakob, A., Lang, H., Joone, G., & van Rensburg, C. E. J. (2011) · PubMed · Cited by 32
HPMA-based polymeric conjugates in anticancer therapeutics
Rani, S., & Gupta, U. D. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.04.007 · Cited by 33
Prodrugs for the improvement of drug absorption via different routes of administration
Balant, L. P., Doelker, É., & Buri, P. A. (1990) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190197 · Cited by 32
“As early as 1975, Ringsdorf ( 30 ) drew attention to the need for tailor - made macromolecular prodrugs with a view to attaching a homing device or directing units, solubilizing units, and using a biostable or biodegradable backbone.”
BackgroundGao, P., Jiang, X. M., Li, J., Nicolas, J., & Ha‐Duong, T. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503503 · Cited by 36
Rajabi, M., Godugu, K., Sudha, T., Bharali, D. J., & Mousa, S. A. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00742 · Cited by 32
Leiske, M. N. (2023) · European Polymer Journal · doi:10.1016/j.eurpolymj.2023.111832 · Cited by 31
Barz, M., Luxenhofer, R., & Schillmeier, M. (2015) · Nanomedicine · doi:10.2217/nnm.15.156 · Cited by 31
Wu, H., Chen, H., Tang, B., Kang, Y., Xu, J., & Zhang, X. (2020) · Langmuir · doi:10.1021/acs.langmuir.9b03325 · Cited by 31
The role of pro-drug therapy in the treatment of cancer
Ferguson, M., Ahmed, F. Y., & Cassidy, J. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0207 · Cited by 31
Mahkam, M., Sharifi‐Sanjani, N., & Entezami, A. A. (2000) · Journal of Bioactive and Compatible Polymers · doi:10.1106/m3wa-3mew-xyyn-v3j4 · Cited by 31
Molecular platforms for targeted drug delivery
Maso, K., Grigoletto, A., Vicent, M. J., & Pasut, G. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.03.001 · Cited by 32
Selective Targeting of Cancer Signaling Pathways with Nanomedicines: Challenges and Progress
Barkat, H. A., Das, S. S., Barkat, M. A., Beg, S., & Hadi, H. A. (2020) · Future Oncology · doi:10.2217/fon-2020-0198 · Cited by 30
Poly(2-oxazoline) – Ferrostatin-1 drug conjugates inhibit ferroptotic cell death
Morrow, J. P., Mazrad, Z. A. I., Bush, A. I., & Kempe, K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.08.004 · Cited by 31
Dextran and Inulin Derivatives of Procainamide
Schacht, E. H., Ruys, L., Vermeersch, J., Remon, J. P., & Duncan, R. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb18401.x · Cited by 30
Intelligent Biohybrid Materials for Therapeutic and Imaging Agent Delivery
Stayton, P. S., Hoffman, A. S., ElSayed, M. E. H., Kulkarni, S., Shimoboji, T., Murthy, N., Bulmuş, V., & Lackey, C. A. (2005) · Proceedings of the IEEE · doi:10.1109/jproc.2005.844619 · Cited by 30
“Ringsdorf first noted the potential of grafted polymers to serve as multifunctional delivery vehicles [12].”
BackgroundAssociation of macromolecular prodrugs consisting of adriamycin bound to poly( L ‐glutamic acid)
Nukui, M., Hoes, K., van den Berg, H., & Feijén, J. (1991) · Die Makromolekulare Chemie · doi:10.1002/macp.1991.021921209 · Cited by 30
Targeting Cancer Stem Cells: Therapeutic and diagnostic strategies by the virtue of nanoparticles
Shrestha, S., Banstola, A., Jeong, J., Seo, J. H., & Yook, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.013 · Cited by 29
Babazadeh, M. (2007) · Journal of Applied Polymer Science · doi:10.1002/app.25913 · Cited by 31
Maciollek, A., Munteanu, M., & Ritter, H. (2009) · Macromolecular Chemistry and Physics · doi:10.1002/macp.200900436 · Cited by 29
Polymeric drugs based on bioactive glycosides for the treatment of brain tumours
López-Donaire, M. L., Parra, J., Vázquez‐Lasa, B., García‐Álvarez, I., Fernández‐Mayoralas, A., López‐Bravo, A., & Román, J. S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.006 · Cited by 29
“Ringsdorf was one of the first person who presented the concept of target polymeric drugs [12] and predicted some important benefits of them against their low molecular weight analogs.”
BackgroundGalactose-Containing Amphiphiles Prepared with a Lipophilic Radical Initiator
Kitano, H., Sohda, K., & Kosaka, A. (1995) · Bioconjugate Chemistry · doi:10.1021/bc00031a016 · Cited by 29
On the design of polymeric 5′-O-ester prodrugs of 3′-azido-2′,3′-dideoxythymidine (AZT)
Troev, K. D., Mitova, V. A., & Ivanov, I. (2010) · Tetrahedron Letters · doi:10.1016/j.tetlet.2010.09.076 · Cited by 28
Biodegradable Block Copolymers and Their Applications for Drug Delivery
Soni, V., Pandey, V., Asati, S., Gour, V., & Tekade, R. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817909-3.00011-x · Cited by 33
Nanomedicine: The Promise and Challenges in Cancer Chemotherapy
Naguib, Y. W., & Cui, Z. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-8739-0_11 · Cited by 29
Can, H. K., Karakuş, G., & Tuzcu, N. (2014) · Polymer Bulletin · doi:10.1007/s00289-014-1230-2 · Cited by 28
“mid-1970s, who called them synthetic polymeric drugs or pharmacologically active polymers [11].”
Synthesis, Radiolabeling, and In Vivo Imaging of PEGylated High-Generation Polyester Dendrimers
McNelles, S. A., Knight, S. D., Janzen, N., Valliant, J. F., & Adronov, A. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00911 · Cited by 32
Synthesis of functional and boronic acid-containing aliphatic polyesters via Suzuki coupling
Kubo, T., Scheutz, G. M., Latty, T. S., & Sumerlin, B. S. (2019) · Chemical Communications · doi:10.1039/c9cc01975h · Cited by 28
Nano-Aggregates: Emerging Delivery Tools for Tumor Therapy
Sharma, V. K., Jain, A., & Soni, V. (2013) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2013007706 · Cited by 27
A polyphosphoester conjugate of melphalan as antitumoral agent
Bogomilova, A., Höhn, M., Günther, M., Herrmann, A., Troev, K. D., Wagner, E., & Schreiner, L. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.007 · Cited by 27
Shahnaz, G., Iqbal, J., Rahmat, D., Perera, G., Laffleur, F., Rossi, D., & Bernkop‐Schnürch, A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.092 · Cited by 27
“The model of covalent conjugation was firstly introduced by Helmut Ringsdorf in 1975, who called them synthetic polymeric drugs or pharmacologically active polymers [17].”
Noninvasive Detection of Passively Targeted Poly(ethylene glycol) Nanocarriers in Tumors
Singh, Y., Gao, D., Gu, Z., Li, S., Stein, S., & Sinko, P. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2003913 · Cited by 27
Targetable Polymeric Anticancer Drugs: Temporal Control of Drug Activity
Kopeček, J. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb27253.x · Cited by 27
Selective Endocytosis of Macromolecular Drug Carriers
Duncan, R. (1987) · Drugs and the pharmaceutical sciences · doi:10.1201/b14193-18 · Cited by 29
Soluble Polymers as Targetable Drug Carriers
Krinick, N. L., & Kopec̆ek, J. (1991) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-75862-1_5 · Cited by 28
Polypept(o)ides – Origins, synthesis, applications and future directions
Bauer, T. A., Simić, L., Guyse, J. F. R. V., Duro‐Castaño, A., Nebot, V. J., & Barz, M. (2024) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2024.101889 · Cited by 29
Oral delivery of anticancer drugs II: the prodrug strategy
Mazzaferro, S., Bouchemal, K., & Ponchel, G. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.08.006 · Cited by 27
“58 Ringsdorf, H. (1975) Structure and properties of pharmacologically active polymers.”
BackgroundDas, D., Gerboth, D., Postma, A., Srinivasan, S., Kern, H. B., Chen, J., Ratner, D. M., Stayton, P. S., & Convertine, A. J. (2016) · Polymer Chemistry · doi:10.1039/c6py01172a · Cited by 26
Advances in Predictive, Preventive and Personalised Medicine
Karabulut, S. (2012) · Cited by 27
Macromolecular Antiproliferative Agents Featuring Dicarboxylato-Chelated Platinum
Komane, L. L., Mukaya, H. E., Neuse, E. W., & van Rensburg, C. E. J. (2007) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-007-9175-7 · Cited by 26
Scheibe, P., Barz, M., Hemmelmann, M., & Zentel, R. (2010) · Langmuir · doi:10.1021/la903725k · Cited by 26
Tumor-binding prodrug micelles of polymer–drug conjugates for anticancer therapy in HeLa cells
Jung, B., Jeong, Y., Min, J., Kim, J.-E., Song, Y., Park, J.-K., Park, J., & Kim, J.-D. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm30534h · Cited by 26
Preparation of Carborane-Containing Polymers by Atom Transfer Radical Polymerization
Gratton, S. E. A., Parrott, M. C., & Adronov, A. (2005) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-006-9000-8 · Cited by 28
Volkmann, L., Köhler, M., Sobotta, F. H., Enke, M., Brendel, J. C., & Schacher, F. H. (2018) · Macromolecules · doi:10.1021/acs.macromol.8b01260 · Cited by 28
Nanomedicines for Malaria Chemotherapy: Encapsulation vs. Polymer Therapeutics
Mvango, S., Matshe, W. M. R., Balogun, A. O., Pilcher, L. A., & Balogun, M. O. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2517-z · Cited by 30
Vascular Nanomedicine: Current Status, Opportunities, and Challenges
Sun, M. T., & Gupta, A. S. (2019) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0039-1692395 · Cited by 27
Swarts, J. C., Neuse, E. W., & Lamprecht, G. J. (1994) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/bf01036539 · Cited by 26
Ouyang, W., & Müller, M. (2006) · Macromolecular Bioscience · doi:10.1002/mabi.200600143 · Cited by 26
Nano-Sized Carriers for Drug Delivery
Sahoo, S. K., Jain, T. K., Reddy, M. K., & Labhasetwar, V. D. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-218-2_13 · Cited by 28
“Polymer chemistry for drug conjugation for drug targeting was conceptualized in 1975 ( 48 ).”
BackgroundSynthesis and evaluation of macromolecular prodrugs of mitomycin C
Marre, A. D., Soyez, H., Schacht, E. H., Shoaibi, M. A., Seymour, L. W., & Říhová, B. (1995) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00058-g · Cited by 26
Gam, G., Jeong, J.-G., Lee, N., Lee, Y., Ha, C., & Cho, W. (1995) · Journal of Applied Polymer Science · doi:10.1002/app.1995.070570210 · Cited by 26
Qiu, G., Zhao, L., Liu, X., Zhao, Q., Liu, F., Liu, Y., Liu, Y., & Gu, H. (2018) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2018.03.010 · Cited by 25
Synthesis and Characterization of Naringenin-Loaded Chitosan-Dextran Sulfate Nanocarrier
Muralidharan, S., & Shanmugam, K. (2020) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-020-09444-2 · Cited by 26
Colombo, P., Boustta, M., Poujol, S., Pinguet, F., Rouanet, P., Bressolle, F., & Vert, M. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.02.004 · Cited by 25
Advances in oral delivery of anti-cancer prodrugs
Jain, A., & Jain, S. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1200554 · Cited by 27
“The concept of PDC as the prodrugs was initially proposed by Ringsdorf in 1975 [138].”
BackgroundSarangthem, V., Seo, B.-Y., Yi, A., Lee, Y.-J., Cheon, S.-H., Kim, S. K., Singh, T. D., Lee, B.-H., & Park, R. (2020) · Nanotheranostics · doi:10.7150/ntno.39804 · Cited by 26
“Nanoparticle- or macromolecule-based drug carriers can be linked to the therapeutic agent covalently and target the perivascular tumor region via passive or active targeting strategies [5-8].”
BackgroundBiotinylated HPMA centered polymeric nanoparticles for Bortezomib delivery
Rani, S., Sahoo, R. K., Nakhate, K. T., Ajazuddin, M., & Gupta, U. D. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119173 · Cited by 26
Dai, X., Eccleston, M., Yue, Z., Slater, N. K. H., & Kaminski, C. F. (2006) · Polymer · doi:10.1016/j.polymer.2006.02.059 · Cited by 25
Pharmaceutical and Medical Applications of Poly-Gamma-Glutamic Acid
Akagi, T., Matsusaki, M., & Akashi, M. (2010) · Microbiology monographs · doi:10.1007/978-3-642-12453-2_7 · Cited by 27
“In the mid-1970s, Ringsdorf propounded a polymer–drug conjugate model that could enhance the delivery of an anticancer drug to a tumor (Ringsdorf 1975).”
BackgroundAdhesion polypeptides are useful for the prevention of peritoneal dissemination of gastric cancer
Matsuoka, T., Chung, K. H.-Y., Yashiro, M., Nishimura, S., Sawada, T., Saiki, I., & Sowa, M. (1998) · Clinical & Experimental Metastasis · doi:10.1023/a:1006573732238 · Cited by 25
“In addition to slow clearance, these peptides have other advantages, such as controlled drug release and reduction of toxicity [45].”
BackgroundOuchi, T., Yamabe, E., Hara, K., Hirai, M., & Ohya, Y. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.09.020 · Cited by 25
Polymeric drug delivery systems
Román, J. S., Gallardo, A., & Levenfeld, B. (1995) · Advanced Materials · doi:10.1002/adma.19950070223 · Cited by 25
Chemical modification of polymers I. Applications and synthetic strategies
Soutif, J., & Brosse, J. (1990) · Reactive Polymers · doi:10.1016/0923-1137(90)90058-c · Cited by 31
Development of N-(2-Hydroxypropyl)Methacrylamide Copolymers as Carriers of Therapeutic Agents
Duncan, R., Kopec̆ek, J., & Lloyd, J. B. (1983) · Springer eBooks · doi:10.1007/978-1-4615-7643-3_6 · Cited by 26
A novel structure of ultra-high-loading small molecules-encapsulated ZIF-8 colloid particles
Duan, P., An, Y., Wei, X., Tian, Y., Guan, D., Liu, X., & Mao, L. (2023) · Nano Research · doi:10.1007/s12274-023-6172-2 · Cited by 25
Historical Overview of Long Acting Injections and Implants
Wright, J. C., & Hoffman, A. S. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0554-2_2 · Cited by 31
“5 ) [ 41 ] .”
BackgroundConjugation of Epitope Peptides with SH Group to Branched Chain Polymeric Polypeptides via Cys(Npys)
Mező, G., Mihala, N., Andreu, D., & Hudecz, F. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990116o · Cited by 24
Breitenbach, B. B., Steiert, E., Konhäuser, M., Vogt, L., Wang, Y., Parekh, S. H., & Wich, P. R. (2019) · Soft Matter · doi:10.1039/c8sm02204f · Cited by 24
Polymer conjugates for drug targeting. From inspired to inspiration!
Duncan, R. (2006) · Journal of drug targeting · doi:10.1080/10611860600833880 · Cited by 24
“New technologies have been proposed for targeted drug delivery including watersoluble polymer-drug conjugates (Ringsdorf 1975), block copolymer micelles and liposomes (Gros et al. 1981).”
BackgroundGautier, S., Boustta, M., & Vert, M. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00079-6 · Cited by 24
Abioye, A. O., Chi‐Tangyie, G., Kola-Mustapha, A. T., Ruparelia, K. C., Beresford, K. J. M., & Arroo, R. (2016) · Pharmaceutical Nanotechnology · doi:10.2174/2211738504666160213001714 · Cited by 26
Polymeric Antitumor Agents on a Molecular and Cellular Level
Dorn, K., Hoerpel, G., & Ringsdorf, H. (1985) · Springer eBooks · doi:10.1007/978-1-4757-0405-1_19 · Cited by 24
Self-citationHydrolysis‐Sensitive Dithiolethione Prodrug Micelles
Hasegawa, U., Tateishi, N., Uyama, H., & van der Vlies, A. J. (2015) · Macromolecular Bioscience · doi:10.1002/mabi.201500156 · Cited by 24
Polymer Therapeutics in Relation to Dentistry
Rojo, L., & Deb, S. (2015) · Frontiers of oral physiology/Frontiers of oral biology · doi:10.1159/000381688 · Cited by 23
A polymer–(multifunctional single-drug) conjugate for combination therapy
Zhou, D., He, S., Cong, Y., Xie, Z., Chen, X., Jing, X., & Huang, Y. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00576k · Cited by 23
Peptide−Poly( l -lysine citramide) Conjugates and their In Vitro Anti-HIV Behavior
Couffin, A., Aubertin, A.-M., Boustta, M., Schmidt, S., Fehrentz, J., Martínez, J., & Vert, M. (2009) · Biomacromolecules · doi:10.1021/bm801376v · Cited by 23
Polymers for medicobiological use
Штильман, М. И. (2010) · Polymer Science Series A · doi:10.1134/s0965545x10090038 · Cited by 25
Kakinoki, A., Kaneo, Y., Tanaka, T., & Hosokawa, Y. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.963 · Cited by 23
Borchmann, D. E., Tarallo, R., Avendano, S., Falanga, A., Carberry, T. P., Galdiero, S., & Weck, M. (2015) · Macromolecules · doi:10.1021/acs.macromol.5b00173 · Cited by 23
Transient Multivalent Nanobody Targeting to CD206-Expressing Cells via PH-Degradable Nanogels
Scherger, M., Bolli, E., Antunes, A. R. P., Arnouk, S. M., Stickdorn, J., Driessche, A. V., Schild, H., Grabbe, S., Geest, B. G. D., Ginderachter, J. A. V., et al. (2020) · Cells · doi:10.3390/cells9102222 · Cited by 25
Chavas, T. E. J., Su, F., Srinivasan, S., Roy, D., Lee, B., Lovelace-Macon, L., Rerolle, G. F., Limqueco, E., Skerrett, S. J., Ratner, D. M., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.031 · Cited by 23
Grigoletto, A., Tedeschini, T., Canato, E., & Pasut, G. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1689 · Cited by 25
Karakuş, G., Polat, Z. A., Yenidünya, A. F., Zengin, H. B., & Karakuş, C. B. (2012) · Polymer International · doi:10.1002/pi.4341 · Cited by 23
Functionalization of poly(oxyethylene phosphonate) under phase-transfer catalyst conditions
Kossev, K. S., Vassilev, A., Popova, Y., Ivanov, I., & Troev, K. D. (2003) · Polymer · doi:10.1016/s0032-3861(03)00081-8 · Cited by 23
Zhao, Y.-J., Wei, W., Su, Z. G., & Ma, G. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.013 · Cited by 24
Zimmermann, U., Pilwat, G., & Vienken, J. (1980) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-81491-4_39 · Cited by 23
Metadata
- Authors
- Ringsdorf, H.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Ringsdorf, Helmut
- Venue
- Journal of Polymer Science: Polymer Symposia
- Publisher
- Wiley
- Published
- 1975-01
- Volume
- 51
- Issue
- 1
- Pages
- 135-153
- ISSN
- 0360-8905 (ISSN-L)
- 1936-0959
- OpenAlex
- W2098279377
- Cited by
- 1,094
- References
- 63
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 34 · 2023: 35 · 2022: 30 · 2021: 35 · 2020: 50 · 2019: 36 · 2018: 29 · 2017: 46 · 2016: 45 · 2015: 47 · 2014: 55 · 2013: 43 · 2012: 48
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Polymer Science Polymer Symposia (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Chemistry › Organic Chemistry › Advanced Polymer Synthesis and Characterization
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Keywords
- macromolecular drugs, comonomer incorporation, polymer-analogous reactions, solubility, toxicity, body distribution, polymer synthesis, biological activity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.